Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | RAF proto-oncogene serine/threonine-protein kinase | ||
| Ligand | BDBM50340954 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_739836 (CHEMBL1762896) | ||
| IC50 | 180±n/a nM | ||
| Citation |  Crew, AP; Bhagwat, SV; Dong, H; Bittner, MA; Chan, A; Chen, X; Coate, H; Cooke, A; Gokhale, PC; Honda, A; Jin, M; Kahler, J; Mantis, C; Mulvihill, MJ; Tavares-Greco, PA; Volk, B; Wang, J; Werner, DS; Arnold, LD; Pachter, JA; Wild, R; Gibson, NW Imidazo[1,5-a]pyrazines: orally efficacious inhibitors of mTORC1 and mTORC2. Bioorg Med Chem Lett21:2092-7 (2011) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| RAF proto-oncogene serine/threonine-protein kinase | |||
| Name: | RAF proto-oncogene serine/threonine-protein kinase | ||
| Synonyms: | C-Raf Protein Kinase | Proto-oncogene c-RAF (RAF1) | RAF | RAF proto-oncogene serine/threonine-protein kinase (C-Raf) | RAF1 | RAF1_HUMAN | Raf-1 | Serine/threonine-protein kinase RAF | Serine/threonine-protein kinase C-Raf | cRaf | ||
| Type: | Serine/threonine-protein kinase | ||
| Mol. Mass.: | 73082.52 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | P04049 | ||
| Residue: | 648 | ||
| Sequence: |
| ||
| BDBM50340954 | |||
| n/a | |||
| Name | BDBM50340954 | ||
| Synonyms: | CHEMBL1762110 | Trans-N-((-4-(8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl)cyclohexyl)methyl)acetamide | ||
| Type | Small organic molecule | ||
| Emp. Form. | C23H26N6O | ||
| Mol. Mass. | 402.4921 | ||
| SMILES | CC(=O)NC[C@H]1CC[C@@H](CC1)c1nc(-c2cc3ccccc3[nH]2)c2c(N)nccn12 |r,wU:8.11,wD:5.4,(30.4,-52.78,;31.44,-51.63,;32.94,-51.96,;30.97,-50.17,;32,-49.03,;31.53,-47.56,;32.56,-46.41,;32.09,-44.94,;30.58,-44.63,;29.54,-45.77,;30.01,-47.24,;30.1,-43.16,;31.01,-41.9,;30.1,-40.65,;30.58,-39.19,;29.67,-37.94,;30.58,-36.7,;30.27,-35.2,;31.41,-34.17,;32.87,-34.65,;33.19,-36.15,;32.04,-37.18,;32.04,-38.72,;28.62,-41.13,;27.29,-40.37,;27.29,-38.83,;25.96,-41.14,;25.96,-42.68,;27.29,-43.45,;28.63,-42.68,)| | ||
| Structure | 
| ||